Note: The MolecuLight i:XTM Imaging Device is available in Canada and the European Union. US FDA De Novo approval pending.
The use of mesh has become the standard practice for hernia repair surgery. Post-surgical mesh-related infections, although rare (<1%), are a challenging complication to treat and necessitate mesh removal.1
Clinical synopsis: This patient was treated for infected mesh approximately one year after hernia repair surgery. MolecuLight i:X fluorescence images revealed bacteria in the wound periphery outside of the region which was routinely being cleaned. These images enabled proper, thorough cleaning of, and around, the site. Based on the MolecuLight i:X images the clinician cut a larger piece of antimicrobial gauze to ensure coverage of the entire region of contamination. No bacteria was observed in the wound periphery at the patient’s next visit.
|Standard Imaging ModeTM||Fluorescence Imaging ModeTM, presence of potentially harmful bacteria indicated by red color.|
|General Patient-Related Challenges||
|Patient’s General Care Paradigm||
|Clinician Stated Utility of the MolecuLight i:X||
MolecuLight Clinical Case 0009.